The ectopic expression of EZH2 alleviates FAK-inhibitor-induced cellular senescence in non-small cell lung cancer cells (Figure 4), further supporting the hypothesis that the FAK–EZH2 axis regulates senescence programming. Here, PTK2 is linked to non-small cell lung carcinoma.